Follow the people · Insider
Harold Bernstein
Harold Bernstein files insider transactions with the SEC as a president, r&d & cmo of Maze Therapeutics (MAZE). We hold 15 disclosed purchases and sales filed since 24 September 2025, 6 of them in the last 90 days.
- Files forMAZE
- Disclosed buys and sells15 in all, 6 in the last 90 days
- Last disclosure8 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 September 2025 — 4 September 2026President, R&D & CMO · Maze Therapeutics (MAZE)86 Form 4 lines · source: SEC Form 4
Everything they disclosed
86 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 9,705 shares of Maze TherapeuticsSEC Form 48 September 2026Common Stock · traded 4 September 2026 · filed 8 September 2026
- ▼ sold on the open market 4,481 shares of Maze TherapeuticsSEC Form 44 September 2026Common Stock · traded 2 September 2026 · filed 4 September 2026
- ▼ sold on the open market 625 shares of Maze TherapeuticsSEC Form 44 September 2026Common Stock · traded 2 September 2026 · filed 4 September 2026
- ▼ sold on the open market 5,130 shares of Maze TherapeuticsSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- ▼ sold on the open market 59 shares of Maze TherapeuticsSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- exercised options over 16,141 shares of Maze TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 16,141 shares of Maze TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- exercised options over 20,000 shares of Maze TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- exercised options over 16,141 shares of Maze Therapeutics (a derivative holding)SEC Form 43 September 2026Stock Option (Right to Buy) · traded 1 September 2026 · filed 3 September 2026
- exercised options over 20,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 September 2026Restricted Stock Units · traded 1 September 2026 · filed 3 September 2026
- exercised options over 16,142 shares of Maze TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- ▼ sold on the open market 16,142 shares of Maze TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- exercised options over 16,142 shares of Maze Therapeutics (a derivative holding)SEC Form 414 August 2026Stock Option (Right to Buy) · traded 13 August 2026 · filed 14 August 2026
- exercised options over 14,609 shares of Maze TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- ▼ sold on the open market 13,409 shares of Maze TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- ▼ sold on the open market 1,200 shares of Maze TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- exercised options over 14,609 shares of Maze Therapeutics (a derivative holding)SEC Form 42 July 2026Stock Option (Right to Buy) · traded 1 July 2026 · filed 2 July 2026
- exercised options over 14,853 shares of Maze TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- ▼ sold on the open market 13,253 shares of Maze TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- ▼ sold on the open market 1,600 shares of Maze TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- exercised options over 14,853 shares of Maze Therapeutics (a derivative holding)SEC Form 43 June 2026Stock Option (Right to Buy) · traded 1 June 2026 · filed 3 June 2026
- exercised options over 15,000 shares of Maze TherapeuticsSEC Form 418 May 2026Common Stock · traded 14 May 2026 · filed 18 May 2026
- ▼ sold on the open market 15,000 shares of Maze TherapeuticsSEC Form 418 May 2026Common Stock · traded 14 May 2026 · filed 18 May 2026
- exercised options over 15,000 shares of Maze Therapeutics (a derivative holding)SEC Form 418 May 2026Stock Option (Right to Buy) · traded 14 May 2026 · filed 18 May 2026
- exercised options over 15,000 shares of Maze TherapeuticsSEC Form 42 April 2026Common Stock · traded 1 April 2026 · filed 2 April 2026
- ▼ sold on the open market 11,352 shares of Maze TherapeuticsSEC Form 42 April 2026Common Stock · traded 1 April 2026 · filed 2 April 2026
- ▼ sold on the open market 3,348 shares of Maze TherapeuticsSEC Form 42 April 2026Common Stock · traded 1 April 2026 · filed 2 April 2026
- ▼ sold on the open market 300 shares of Maze TherapeuticsSEC Form 42 April 2026Common Stock · traded 1 April 2026 · filed 2 April 2026
- exercised options over 15,000 shares of Maze Therapeutics (a derivative holding)SEC Form 42 April 2026Stock Option (Right to Buy) · traded 1 April 2026 · filed 2 April 2026
- exercised options over 15,000 shares of Maze TherapeuticsSEC Form 420 March 2026Common Stock · traded 20 March 2026 · filed 20 March 2026
- ▼ sold on the open market 6,161 shares of Maze TherapeuticsSEC Form 420 March 2026Common Stock · traded 20 March 2026 · filed 20 March 2026
- ▼ sold on the open market 3,795 shares of Maze TherapeuticsSEC Form 420 March 2026Common Stock · traded 20 March 2026 · filed 20 March 2026
- exercised options over 15,000 shares of Maze Therapeutics (a derivative holding)SEC Form 420 March 2026Stock Option (Right to Buy) · traded 20 March 2026 · filed 20 March 2026
- ▼ sold on the open market 5,044 shares of Maze TherapeuticsSEC Form 420 March 2026Common Stock · traded 20 March 2026 · filed 20 March 2026
- exercised options over 15,000 shares of Maze Therapeutics (a derivative holding)SEC Form 420 March 2026Stock Option (Right to Buy) · traded 20 March 2026 · filed 20 March 2026
- exercised options over 15,000 shares of Maze TherapeuticsSEC Form 420 March 2026Common Stock · traded 20 March 2026 · filed 20 March 2026
- ▼ sold on the open market 6,161 shares of Maze TherapeuticsSEC Form 420 March 2026Common Stock · traded 20 March 2026 · filed 20 March 2026
- ▼ sold on the open market 3,795 shares of Maze TherapeuticsSEC Form 420 March 2026Common Stock · traded 20 March 2026 · filed 20 March 2026
- ▼ sold on the open market 5,044 shares of Maze TherapeuticsSEC Form 420 March 2026Common Stock · traded 20 March 2026 · filed 20 March 2026
- exercised options over 30,000 shares of Maze TherapeuticsSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- ▼ sold on the open market 29,652 shares of Maze TherapeuticsSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- ▼ sold on the open market 348 shares of Maze TherapeuticsSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- exercised options over 30,000 shares of Maze Therapeutics (a derivative holding)SEC Form 412 March 2026Stock Option (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- exercised options over 30,000 shares of Maze Therapeutics (a derivative holding)SEC Form 412 March 2026Stock Option (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- exercised options over 30,000 shares of Maze TherapeuticsSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- ▼ sold on the open market 29,652 shares of Maze TherapeuticsSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- ▼ sold on the open market 348 shares of Maze TherapeuticsSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- was granted 48,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (Right to Buy) · traded 2 March 2026 · filed 3 March 2026
- was granted 24,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- was granted 48,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (Right to Buy) · traded 2 March 2026 · filed 3 March 2026
- was granted 24,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- exercised options over 15,000 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 600 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 8,364 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- exercised options over 15,000 shares of Maze Therapeutics (a derivative holding)SEC Form 44 February 2026Stock Option (Right to Buy) · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 5,936 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 100 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- exercised options over 15,000 shares of Maze Therapeutics (a derivative holding)SEC Form 44 February 2026Stock Option (Right to Buy) · traded 2 February 2026 · filed 4 February 2026
- exercised options over 15,000 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 600 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 8,364 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 5,936 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 100 shares of Maze TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- exercised options over 25,156 shares of Maze TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 25,156 shares of Maze TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- exercised options over 25,156 shares of Maze Therapeutics (a derivative holding)SEC Form 49 January 2026Stock Option (Right to Buy) · traded 7 January 2026 · filed 9 January 2026
- exercised options over 25,156 shares of Maze Therapeutics (a derivative holding)SEC Form 49 January 2026Stock Option (Right to Buy) · traded 7 January 2026 · filed 9 January 2026
- exercised options over 25,156 shares of Maze TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 25,156 shares of Maze TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- exercised options over 4,432 shares of Maze TherapeuticsSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 4,432 shares of Maze TherapeuticsSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- exercised options over 412 shares of Maze TherapeuticsSEC Form 46 January 2026Common Stock · traded 5 January 2026 · filed 6 January 2026
- exercised options over 4,432 shares of Maze Therapeutics (a derivative holding)SEC Form 46 January 2026Stock Option (Right to Buy) · traded 2 January 2026 · filed 6 January 2026
- exercised options over 412 shares of Maze Therapeutics (a derivative holding)SEC Form 46 January 2026Stock Option (Right to Buy) · traded 5 January 2026 · filed 6 January 2026
- ▼ sold on the open market 412 shares of Maze TherapeuticsSEC Form 46 January 2026Common Stock · traded 5 January 2026 · filed 6 January 2026
- exercised options over 4,432 shares of Maze Therapeutics (a derivative holding)SEC Form 46 January 2026Stock Option (Right to Buy) · traded 2 January 2026 · filed 6 January 2026
- exercised options over 412 shares of Maze Therapeutics (a derivative holding)SEC Form 46 January 2026Stock Option (Right to Buy) · traded 5 January 2026 · filed 6 January 2026
- exercised options over 4,432 shares of Maze TherapeuticsSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 4,432 shares of Maze TherapeuticsSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- exercised options over 412 shares of Maze TherapeuticsSEC Form 46 January 2026Common Stock · traded 5 January 2026 · filed 6 January 2026
- ▼ sold on the open market 412 shares of Maze TherapeuticsSEC Form 46 January 2026Common Stock · traded 5 January 2026 · filed 6 January 2026
- exercised options over 45,000 shares of Maze Therapeutics (a derivative holding)SEC Form 431 December 2025Stock Option (Right to Buy) · traded 29 December 2025 · filed 31 December 2025
- exercised options over 45,000 shares of Maze TherapeuticsSEC Form 431 December 2025Common Stock · traded 29 December 2025 · filed 31 December 2025
- ▼ sold on the open market 27,800 shares of Maze TherapeuticsSEC Form 431 December 2025Common Stock · traded 29 December 2025 · filed 31 December 2025
- ▼ sold on the open market 17,200 shares of Maze TherapeuticsSEC Form 431 December 2025Common Stock · traded 29 December 2025 · filed 31 December 2025
- was granted 40,000 shares of Maze Therapeutics (a derivative holding)SEC Form 424 September 2025Restricted Stock Units · traded 22 September 2025 · filed 24 September 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.